IPAC23 APK
- Developer
-
- Current Version
- 3.0.1.6
- Date Published
- May 08, 2023
- File Size
- 14.6 MB
- Package ID
- pl.pcss.ipac2023
- Price
- $ 0.00
- Downloads
- 49+
- Category
- Android Apps
- Genre
- Productivity
Download APK
Safe
APK Version History
- Version
- 3.0.1.6 (360)
- Architecture
- universal
- Release Date
- May 08, 2023
- Requirement
- Android 5.0+
Download [ 14.6 MB ]
Safe
About Radio FM 90s
We are pleased to announce the 14th International Particle Accelerator Conference (IPAC’23) to be held in Venice, Italy from 7 to 12 May 2023 at the Venice Convention Centre.
IPAC is the main international event for the worldwide particle accelerator field and industry. The IPAC’23 edition, jointly organised by the accelerator communities in Europe, Americas and Asia, is hosted by Istituto Nazionale di Fisica Nucleare and Elettra Sincrotrone Trieste.
Attendees will learn about world-wide highlights in cutting-edge accelerator research and development, hear about new projects, gain the latest insights into accelerator facilities across the globe and will have the opportunity to meet their peers and to make new business contacts.
The IPAC23 app provides the most up-to-date information on the conference about the scientific programme; the industry sessions; the authors; logistic; exhibitors & sponsors.
IPAC is the main international event for the worldwide particle accelerator field and industry. The IPAC’23 edition, jointly organised by the accelerator communities in Europe, Americas and Asia, is hosted by Istituto Nazionale di Fisica Nucleare and Elettra Sincrotrone Trieste.
Attendees will learn about world-wide highlights in cutting-edge accelerator research and development, hear about new projects, gain the latest insights into accelerator facilities across the globe and will have the opportunity to meet their peers and to make new business contacts.
The IPAC23 app provides the most up-to-date information on the conference about the scientific programme; the industry sessions; the authors; logistic; exhibitors & sponsors.